10.1111/nmo.12826 Neurogastroenterol
Keshani M, Alikiaii B, Babaei Z, Askari G, Heidari Z, Sharma M, et al
The clinical permutation chosen should therefore reflect not just a woman's symptom profile but her metabolic risk factors, body composition goals, cognitive health priorities, and cardiovascular history
Why Insurance Companies Restrict GLP-1 Coverage Insurers cite rising medication costs and limited clinical evidence comparing GLP-1 therapy to lifestyle interventions as primary reasons for restrictions
this relationship seems to play a relatively minor role, as far as current research shows
Among these Americans, the top reason is a preference to manage weight through traditional methods, as well as concerns over side effects